Emerging evidence has suggested a role for p53 in obesity- and ageing-related cardiometabolic disorders, such as insulin resistance, endothelial dysfunction, liver and heart diseases5, 6, 7, 8, 9, 10. This evidence concerns the gene TP53 and Obesity.